Randomized clinical trial: the effects of mirtazapine in functional dyspepsia patients
Background: Functional dyspepsia (FD) is one of the most common gastrointestinal disorders worldwide. Currently, anti-gastric drugs, gastric acid inhibitors, prokinetic drugs, and mucosal protective drugs are widely used in FD patients, however, only a small proportion of patients benefit from these...
Saved in:
Main Authors: | Lina Cao, Gaozhong Li, Jingmei Cao, Fuxin Li, Wei Han |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848241311129 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pediatric Tuina for the treatment of functional dyspepsia: A systematic review and meta-analysis of randomized controlled trials
by: Na-Yeon Ha, et al.
Published: (2025-03-01) -
Systematic Approach toward the Clinical Diagnosis of Functional Dyspepsia
by: Pierre Paré
Published: (1999-01-01) -
Duodenal Eosinophilia in Functional Dyspepsia
by: A. S. Silaeva, et al.
Published: (2023-08-01) -
Functional dyspepsia and gut microbiome
by: H. Mori, et al.
Published: (2024-10-01) -
Antioxidants and Cognitive-Behavioral Therapy in Patients with Functional Dyspepsia
by: T. V. Sapozhnikova, et al.
Published: (2023-09-01)